Alector Upgraded, Analyst Sees High Reward Potential Ahead of Alzheimer's Disease Candidate's Phase 2 Results

Stifel has upgraded Alector Inc ALEC, noting that while Alzheimer's is a very high risk, the probability of success for AL002 (TREM2 agonist) is above…

Related Keywords

,Alector Inc ,News ,Ggregator ,Reaking News ,Uration ,Media ,